Snowden Capital Advisors LLC Vertex Pharmaceuticals Inc Transaction History

Snowden Capital Advisors LLC

$3.29 Billion
Q3 2024

A detailed history of Snowden Capital Advisors LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Snowden Capital Advisors LLC holds 11,387 shares of VRTX stock, worth $5.32 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

11,387

Previous 13,993 18.62%

Holding current value

$5.32 Million

Previous $6.56 Million 19.26%

% of portfolio

0.16%

Previous 0.2%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$460.0 - $505.78 $1.2 Million - $1.32 Million	-2,606 Reduced 18.62%	11,387 $5.3 Million
Q2 2024 Aug 14, 2024	SELL	$392.81 - $485.53 $139,054 - $171,877	-354 Reduced 2.47%	13,993 $6.56 Million
Q1 2024 May 15, 2024	BUY	$407.69 - $446.08 $101,922 - $111,520	250 Added 1.77%	14,347 $6 Million
Q4 2023 Feb 14, 2024	BUY	$343.0 - $410.68 $184,877 - $221,356	539 Added 3.98%	14,097 $5.74 Million
Q3 2023 Nov 14, 2023	SELL	$338.18 - $362.46 $28,407 - $30,446	-84 Reduced 0.62%	13,558 $4.71 Million
Q2 2023 Aug 14, 2023	BUY	$314.42 - $351.91 $114,448 - $128,095	364 Added 2.74%	13,642 $4.8 Million
Q1 2023 May 15, 2023	SELL	$283.23 - $323.1 $19,542 - $22,293	-69 Reduced 0.52%	13,278 $4.18 Million
Q4 2022 Feb 13, 2023	BUY	$285.76 - $321.48 $2.44 Million - $2.74 Million	8,535 Added 177.37%	13,347 $3.85 Million
Q3 2022 Nov 09, 2022	SELL	$273.83 - $305.53 $88,447 - $98,686	-323 Reduced 6.29%	4,812 $1.39 Million
Q2 2022 Aug 12, 2022	BUY	$234.96 - $292.55 $280,307 - $349,012	1,193 Added 30.26%	5,135 $1.45 Million
Q1 2022 May 16, 2022	BUY	$221.42 - $260.97 $791,133 - $932,445	3,573 Added 968.29%	3,942 $1.03 Million
Q4 2021 Feb 14, 2022	BUY	$177.01 - $223.45 $65,316 - $82,453	369 New	369 $81,000
Q3 2021 Feb 05, 2024	SELL	$181.39 - $202.99 $1.75 Million - $1.96 Million	-9,674 Reduced 71.35%	3,884 $705 Million
Q2 2021 Jan 08, 2024	BUY	$187.49 - $221.1 $99,932 - $117,846	533 Added 46.39%	1,682 $339 Million
Q1 2021 Jan 08, 2024	BUY	$207.02 - $241.31 $41,818 - $48,744	202 Added 21.33%	1,149 $247 Million
Q4 2020 Jan 08, 2024	BUY	$207.01 - $276.09 $20,286 - $27,056	98 Added 11.54%	947 $224 Million
Q3 2020 Jan 08, 2024	BUY	$255.65 - $303.1 $511 - $606	2 Added 0.24%	849 $231 Million
Q2 2020 Jan 08, 2024	SELL	$225.48 - $295.8 $5,411 - $7,099	-24 Reduced 2.76%	847 $246 Million
Q1 2020 Jan 08, 2024	SELL	$199.77 - $247.81 $9.89 Million - $12.3 Million	-49,529 Reduced 98.27%	871 $207 Million
Q4 2019 Jan 08, 2024	BUY	$166.71 - $223.91 $150,039 - $201,519	900 Added 1.82%	50,400 $110 Million
Q3 2019 Jan 08, 2024	BUY	$166.23 - $187.09 $5.97 Million - $6.72 Million	35,942 Added 265.1%	49,500 $83.9 Million

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $120B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Snowden Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Snowden Capital Advisors LLC with notifications on news.

Account

Snowden Capital Advisors LLC Vertex Pharmaceuticals Inc Transaction History